These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16331529)

  • 1. Guess the diagnosis. Lymphoma or sarcoidosis.
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1485, 1489. PubMed ID: 16331529
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sarcoidosis-lymphoma syndrome].
    Partanen A; Pukkila S; Jantunen E
    Duodecim; 2016; 132(7):661-5. PubMed ID: 27188091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing PET/CT manifestation of neurolymphomatosis.
    Strobel K; Pestalozzi B; Ciernik I; Schaefer NG; Koma AY; Hany TF
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1244. PubMed ID: 16823555
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.
    Li YJ; Zhang Y; Gao S; Bai RJ
    Clin Nucl Med; 2007 Mar; 32(3):262-4. PubMed ID: 17314619
    [No Abstract]   [Full Text] [Related]  

  • 5. Variable problems in lymphomas: CASE 2. Sarcoidosis mimicking progressive lymphoma.
    Hollister D; Lee MS; Eisen RN; Fey C; Portlock CS
    J Clin Oncol; 2005 Nov; 23(31):8113-6. PubMed ID: 16258110
    [No Abstract]   [Full Text] [Related]  

  • 6. False-positive uptake of FDG in hepatic sarcoidosis.
    Guglielmi AN; Kim BY; Bybel B; Slifkin N
    Clin Nucl Med; 2006 Mar; 31(3):175. PubMed ID: 16495745
    [No Abstract]   [Full Text] [Related]  

  • 7. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
    Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
    Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
    [No Abstract]   [Full Text] [Related]  

  • 8. [Application of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis and therapy of patients with sarcoidosis].
    Li D; Lü PX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):447-50. PubMed ID: 24103209
    [No Abstract]   [Full Text] [Related]  

  • 9. Osseous Sarcoidosis Mimicking Metastatic Cancer on Positron Emission Tomography.
    Ashamalla M; Koutroumpakis E; McCarthy L; Hegener P; Grimm R; Mehdi S
    J Oncol Pract; 2016 Jul; 12(7):697-8. PubMed ID: 27407163
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma.
    Stokkel MP; van der Hiel B; Olmos RV; Hoefnagel K
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):919-20. PubMed ID: 22286771
    [No Abstract]   [Full Text] [Related]  

  • 11. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
    Lewis PJ; Salama A
    J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT.
    Prabhakar HB; Rabinowitz CB; Gibbons FK; O'Donnell WJ; Shepard JA; Aquino SL
    AJR Am J Roentgenol; 2008 Mar; 190(3 Suppl):S1-6. PubMed ID: 18287458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality evaluation of cardiac sarcoidosis.
    Manabe O; Oyama-Manabe N; Ohira H; Tsutsui H; Tamaki N
    J Nucl Cardiol; 2012 Jun; 19(3):621-4. PubMed ID: 22422295
    [No Abstract]   [Full Text] [Related]  

  • 14. Reticuloendothelial system involvement in untreated sarcoidosis patients as assessed by 18F-FDG PET scanning.
    Kalkanis A; Judson MA; Kalkanis D; Vavougios GD; Malamitsi J; Georgou E
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):423-425. PubMed ID: 28079858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Sarcoidosis Detected by (18)F-Fluorodeoxyglucose Positron Emission Tomography.
    García JR; Sánchez R; Álvarez Moro FJ
    Rev Esp Cardiol (Engl Ed); 2016 Mar; 69(3):323. PubMed ID: 26507961
    [No Abstract]   [Full Text] [Related]  

  • 16. Fallacy of Quantifying Lymphoma Activity by Scaling to the Liver in [18F]Fluorodeoxyglucose Positron Emission Tomography (Deauville criteria).
    Keramida G; Peters AM
    J Clin Oncol; 2015 Dec; 33(34):4120-1. PubMed ID: 26304889
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal and abnormal patterns of 18F-fluorodeoxyglucose PET/CT in lymphoma.
    Bar-Shalom R
    Radiol Clin North Am; 2007 Jul; 45(4):677-88, vi-vii. PubMed ID: 17706532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer or inflammation? A Holy Grail for nuclear medicine.
    Larson SM
    J Nucl Med; 1994 Oct; 35(10):1653-5. PubMed ID: 7931666
    [No Abstract]   [Full Text] [Related]  

  • 19. Imaging of sarcoidosis: self-assessment module.
    Prabhakar HB; Rabinowitz CB; Chew FS
    AJR Am J Roentgenol; 2008 Mar; 190(3 Suppl):S7-10. PubMed ID: 18321847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-positron emission tomographic imaging in carcinoma of the breast: interference by massive sarcoidosis.
    Garcia CA; Rosenberg RJ; Spencer RP
    Clin Nucl Med; 2003 Mar; 28(3):218-9. PubMed ID: 12592129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.